Hillhouse Capital Management - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 62 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q2 2018. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
Hillhouse Capital Management ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q3 2018$2,087,000
-13.6%
865,9230.0%0.06%
+36.6%
Q2 2018$2,416,000
-41.3%
865,9230.0%0.04%
-43.8%
Q1 2018$4,113,000
-18.5%
865,9230.0%0.07%
-15.1%
Q4 2017$5,048,000
+177.7%
865,9230.0%0.09%
+186.7%
Q3 2017$1,818,000
-55.1%
865,9230.0%0.03%
-51.6%
Q2 2017$4,053,000
-40.2%
865,9230.0%0.06%
-52.7%
Q1 2017$6,772,000
-36.2%
865,9230.0%0.13%
-44.7%
Q4 2016$10,616,000
-10.8%
865,923
+13.4%
0.24%
-2.5%
Q3 2016$11,907,000763,7900.24%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q2 2018
NameSharesValueWeighting ↓
VHCP Management III, LLC 848,610$2,749,0002.00%
GREAT POINT PARTNERS LLC 3,045,423$9,867,0001.25%
NEA Management Company, LLC 5,556,778$18,004,0000.71%
VHCP Management II, LLC 501,390$1,625,0000.70%
SECTORAL ASSET MANAGEMENT INC 1,581,728$5,125,0000.70%
HARBOURVEST PARTNERS LLC 440,627$1,428,0000.68%
EAM Investors, LLC 596,871$1,934,0000.52%
EAM Global Investors LLC 252,778$819,0000.45%
Avoro Capital Advisors LLC 1,300,000$4,212,0000.25%
Ghost Tree Capital, LLC 190,000$616,0000.22%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders